Sign Out
Pregnancy: There are no adequate data from the use of topical Clobetasol propionate in pregnant women. Studies in animals have shown reproductive toxicity.
Use during pregnancy only if the potential benefit justifies the potential risk to the foetus.
Lactation: Systemically administered corticosteroids pass into breast milk. Damage to the infant is not reported to date. Nevertheless, as there are no adequate data on the possible milk transfer of topical clobetasol propionate and its biological or clinical repercussions.
Clobetasol propionate should not be prescribed to breastfeeding women unless clearly indicated.
Fertility: No clinical data available.
Continue with Google